Anil K. Singhal

Insider Reports History

Entity
Individual
Location
C/O Trisalus Life Sciences, Inc., 6272 W. 91 St Avenue, Westminster, CO
Signature
/s/ Jonathan Owen, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anil K. Singhal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Werewolf Therapeutics, Inc. Director Stock Option (right to buy) 45K Feb 19, 2025 Direct
TriSalus Life Sciences, Inc. Director Director stock option (right to buy) 15K Aug 13, 2024 Direct

Insider Reports Filed by Anil K. Singhal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HOWL Werewolf Therapeutics, Inc. Feb 19, 2025 1 $0 4 Feb 21, 2025 Director
HOWL Werewolf Therapeutics, Inc. Feb 19, 2025 0 $0 3 Feb 21, 2025 Director
TLSI TriSalus Life Sciences, Inc. Aug 13, 2024 1 $0 4 Aug 21, 2024 Director
TLSI TriSalus Life Sciences, Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 Director
TLSI TriSalus Life Sciences, Inc. Aug 10, 2023 0 $0 3 Aug 14, 2023 Director